Highlights Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:24:32 12/02/2026 pm IST			5-day change	1st Jan Change
374.25 ^INR	-0.31%		+0.01%	-9.13%

04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Aarti Drugs dividend 2 rupees per share	RE

Highlights

03/02	Aarti Drugs dividend 2 rupees per share	RE
03/02	Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
03/02	Aarti Drugs Dec-quarter Consol Net Profit 405.4 Million Rupees	RE
03/02	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2025-26	CI
08/11	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
18/25/18	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
07/25/07	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT
06/25/06	Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
06/25/06	Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees	RE
14/25/14	US FDA Removes Import Alert on Aarti Drugs Limited's API Manufacturing Facility	CI
04/25/04	For interim dividend	FA
03/25/03	Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine	RE
30/25/30	Aarti Drugs' Consolidated Net Profit Rises in Fiscal Q3	MT
29/25/29	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2024-25	CI
10/25/10	Aarti Drugs to Acquire 26% Stake in Renewable Energy Company	MT
18/24/18	Aarti Drugs Restores Manufacturing Actitvity at Tarapur, India Unit	MT
26/24/26	Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on August 26, 2024.	CI
19/24/19	Aarti Drugs Limited's Equity Buyback announced on August 26, 2024 has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	CI
26/24/26	Aarti Drugs Gets Board Nod to Buy Back Shares of Up to INR598.5 Million	MT
26/24/26	Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	CI
26/24/26	Aarti Drugs Limited authorizes a Buyback Plan.	CI
21/24/21	Aarti Drugs Limited's Board intends to launch an Equity Buyback on August 26, 2024.	CI
02/24/02	Aarti Drugs Arm's Baddi, India Plant Gets Establishment Inspection Report from US FDA	MT
26/24/26	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
03/24/03	Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Highlights

Filters